Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 951 000 KRW 0.21%
Market Cap: 67.7T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

DCF Value

This DCF valuation model was created by Alpha Spread and was last updated on Dec 24, 2024.

Estimated DCF Value of one 207940 stock is 255 812.39 KRW. Compared to the current market price of 951 000 KRW, the stock is Overvalued by 73%.

DCF Value
Base Case
255 812.39 KRW
Overvaluation 73%
DCF Value
Price
Worst Case
Base Case
Best Case
255 812.39
DCF Value
Worst Case
Base Case
Best Case
Hide
DCF Value: 255 812.39 KRW

Present Value Calculation

This block is the starting point of the DCF valuation process. It calculates the present value of a company's forecasted cash flows based on selected operating model. Adjust key parameters like discount rate and terminal growth, and alter inputs such as revenue growth and margins to see their impact on valuation.

DCF Model
Base Case Scenario

The present value of cash flows over the next 5 years amounts to 3.8T KRW. The present value of the terminal value is 14.4T KRW. The total present value equals 18.2T KRW.
Forecast Period
Years
Discount Rate
%
Show All DCF Settings
Terminal Growth
%
Hide DCF Settings
Save

DCF Value Calculation

This stage translates the present value into DCF value per share. For firm valuation models, it adjusts present value for debt and assets to derive equity value (skipped if using equity valuation model). Finally, this equity value is divided by the number of shares to determine the DCF value per share.

Present Value to DCF Value
Capital Structure

Present Value 18.2T KRW
Equity Value 18.2T KRW
/ Shares Outstanding 71.2m
207940 DCF Value 255 812.39 KRW
Overvalued by 73%

You are using the equity valuation model. In this approach, further calculations for converting firm value to equity value are not required. The present value, obtained in the present value calculation block, already represents the equity value.

The DCF value per share is derived by dividing the present value by the number of shares:

Present Value
18.2T KRW
/
Number of Shares
71.2m
=
DCF Value
255 812.39 KRW

Valuation Analysis

Sensitivity Analysis
DCF Value Sensitivity Analysis

Sensitivity Analysis assesses how changes in key factors like revenue growth, margin, and discount rate affect a stock's DCF value. By visualizing various scenarios, from significant downturns to optimistic growth, this tool helps you understand potential valuation shifts, aiding in risk assessment and strategic decision-making.

DCF Financials
Financials used in DCF Calculation

Revenue
5T 8.5T
Net Income
1.2T 2.1T
FCFE
556.4B 1.5T

See Also

Discover More

What is the DCF value of one 207940 stock?

Estimated DCF Value of one 207940 stock is 255 812.39 KRW. Compared to the current market price of 951 000 KRW, the stock is Overvalued by 73%.

The true DCF Value lies somewhere between the worst-case and best-case scenario values. This is because the future is not predetermined, and the stock's DCF Value is based almost entirely on the future of the company. Knowing the full range of possible stock DCF values gives a complete picture of the investment risks and opportunities.

How was the DCF Value calculated?

1. Present Value Calculation. Utilizing the DCF operating model, Samsung Biologics Co Ltd's future cash flows are projected and then discounted using a chosen discount rate to determine its Present Value, which is calculated at 18.2T KRW.

2. DCF Value Calculation. The company's capital structure is employed to derive the total Equity Value from the previously calculated Present Value of the cash flow. This Equity Value, when divided by the total number of outstanding shares, yields the DCF Value of 255 812.39 KRW per share.

Back to Top
//